lilly glp 1 drug Novo, weight-loss drugs should be first option obesity treatments, European doctors say Lilly's Trulicity joins pay-for-performance trend

Mann JFE, Hansen T, Idorn T et al (2020) Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 17 randomised controlled trials

"Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies." Clinical Medicine Insights: Reproductive Health , vol

Hypothalamic integrity is necessary for sustained weight loss after bariatric surgery: a prospective, cross-sectional study

Movement

In terms of the reduction in total testosterone, 9 studies (with 264 and 223 subjects from the experimental and control groups, respectively) were included in the analysis

Cent Eur J Immunol